Measuring whole-body neutrophil redistribution using a dedicated whole-body counter and ultra-low doses of 111Indium

European Journal of Clinical Investigation

Volumn 41, Issue 1, 2011, Pages 77-83

  Szczepura, Katherine R ^a   Ruparelia, Prina ^a   Solanki, Chandra K ^b   Balan, Kottekkattu ^b   Newbold, Paul ^c   Summers, Charlotte ^a   Chilvers, Edwin R ^a   Peters, A Michael ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c ASTRAZENECA   (United Kingdom)

Author keywords

111In neutrophils; Bone marrow; Liver; Spleen; Whole body counting

Indexed keywords

INDIUM 111;

ARTICLE; ASTHMA; BRONCHIECTASIS; CELL HOMING; CELLULAR DISTRIBUTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; NEUTROPHIL; PRIORITY JOURNAL; SMOKING; WHOLE BODY IMAGING;

ADULT; ASTHMA; BONE MARROW; BRONCHIECTASIS; CASE-CONTROL STUDIES; HUMANS; INDIUM RADIOISOTOPES; NEUTROPHILS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; WHOLE-BODY COUNTING;

EID: 78650071739     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2010.02382.x     Document Type: Article

References (23)

1. Saverymuttu SH, Peters AM, Keshavarzian A, Reavy HJ, Lavender JP. The kinetics of 111-indium distribution following injection of 111-indium labelled autologous granulocytes in man. Br J Haematol 1985;61:675-85.
2. Weiblen BJ, Forstrom L, McCullough J. Studies of the kinetics of indium-111-labeled granulocytes. J Lab Clin Med 1979;94:246-55.
3. Suratt BT, Young SK, Lieber J, Nick JA, Henson PM, Worthen GS. Neutrophil maturation and activation determine anatomic site of clearance from circulation. Am J Physiol Lung Cell Mol Physiol 2001;281:L913-L921.
4. Suratt BT, Petty JM, Young SK, Malcolm AC, Lieber JG, Nick JA et al. Role of the CXCR4/SDF-1 chemokine axis in circulating neutrophil homeostasis. Blood 2004;104:565-71.
5. Furze RC, Rankin SM. Neutrophil mobilization and clearance in the bone marrow. Immunology 2008;125:281-8.
6. Furze RC, Rankin SM. The role of the bone marrow in neutrophil clearance under homeostatic conditions in the mouse. FASEB J 2008;22:3111-9.
7. Martin C, Burdon PC, Bridger G, Gutierrez-Ramos JC, Williams TJ, Rankin SM. Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence. Immunity 2003;19:583-93.
8. Athens JW, Haab OP, Raab SO, Mauer AM, Ashenbrucker H, Cartwright GE et al. Leukokinetic studies. IV. The total blood, circulating and marginal granulocyte pools and the granulocyte turnover rate in normal subjects. J Clin Invest 1961;40:989-95.
9. Dancey JT, Deubelbeiss KA, Harker LA, Finch CA. Neutrophil kinetics in man. J Clin Invest 1976;58:705-15.
10. Peters AM, Saverymuttu SH, Bell RN, Lavender JP. Quantification of the distribution of the marginating granulocyte pool in man. Scand J Haematol 1985;34:111-20.
11. Ussov Yu, Aktolun C, Myers MJ, Jamar F, Peters AM. Granulocyte margination in bone marrow: comparison with margination in the spleen and liver. Scand J Clin Lab Invest 1995;55:87-96.
12. Saverymuttu SH, Peters AM, Lavender JP, Pepys MB, Hodgson HJ, Chadwick VS. Quantitative fecal indium-111-labeled leukocyte excretion in the assessment of disease in Crohn's disease. Gastroenterology 1983;85:1333-9.
13. Currie DC, Saverymuttu SH, Peters AM, Needham SG, George P, Dhillon DP et al. Indium-111-labelled granulocyte accumulation in respiratory tract of patients with bronchiectasis. Lancet 1987;1:1335-9.
14. 111indium from reticuloendothelial cells. J Clin Pathol 1982;35:507-9.
15. Carpani de Kaski M, Peters AM, Knight D, Stuttle AW, Lavender JP, Hodgson HJ. In-111 whole body retention: a new method for quantification of disease activity in inflammatory bowel disease. J Nucl Med 1992;33:756-62.
16. Cheow HK, Voutnis DD, Evans JW, Szczepura KR, Swift EA, Bird NJ et al. Quantification of disease activity in patients undergoing leucocyte scintigraphy for suspected inflammatory bowel disease. Eur J Nucl Med Mol Imaging 2005;32:329-37.
17. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23:932-46.
18. Pasteur MC, Bilton D, Hill AT. Guideline for non-CF bronchiectasis. Thorax 2010;65:i1-i58.
19. Peters AM, Roddie ME, Danpure HJ, Osman S, Zacharopoulos GP, George P et al. Tc-99m HMPAO labelled leucocytes: comparison with In-111-tropolonate labelled granulocytes. Nucl Med Commun 1988;9:449-63.
20. Peters AM. Just how big is the pulmonary granulocyte pool? Clin Sci 1998;94:7-19.
21. Ussov WY, Peters AM, Glass DM, Gunasekera RD, Hughes JMB. Measurement of the pulmonary vascular granulocyte pool. J Appl Physiol 1995;78:1388-95.
22. 111indium labelled granulocytes. Relationship to labelling techniques. Scand J Haematol 1983;30:151-60.
23. Sinden NJ, Stockley RA. Systemic inflammation and comorbidity in COPD: a result of 'overspill' of inflammatory mediators from the lungs? Review of the evidence. Thorax 2010; [Epub ahead of print].